Benzenamine,4-[(6,7-Dimethoxy-4-Quinolinyl)oxy]-; [4-[(6,7-Dimethoxyquinolin-4-yl)oxy]Phenyl]Amine; 4-[(6,7-Dimethoxyquinolin-4-yl)oxy]Aniline;6,7-Dimethoxy-4-(4-Aminophenoxy)Quichemicalbooknoline; Benzemine,4-[(6,7-Dimethoxy-4-Quinolinyl)oxy]-; 4-[(6,7-Dimethoxy-4-Quinolinyl)oxy]-Benzenamine;4-(2,3-Dimethoxynaphthalen-5-Yloxy)Benzenamine; Intermediate1Ofcabozantinib

Secukinumab

CAS:1229022-83-6

Brief Introduction

Secukinumab is a high-affinity monoclonal antibody directed against interleukin (IL-17A). Secukinumab (AIN457) is a first-in-class anti-IL-17 agent studied in plaque psoriasis, ankylosing spondylitis and psoriatic arthritis.

Axitinib

MSDS

CAS:319460-85-0

Molecular Formula:C22H18N4OS

Alias

More Information

N-Methyl-2-{[3-((E)-2-Pyridin-2-Ylvinyl)-1H-Indazol-6-YL]Sulfanyl}Benzamide; _|_; N-Methyl-2-((3-((1E)-2-(Pyridin-2-yl)Ethenyl)-1H-Indazol-6-yl)Sulfanyl)Benzamide; Avermectinb; Axitinibforresearch; AG013736; N-Methyl-2-[[3-[(1E)-2-(2-Pyridinyl)Ethenyl]-1H-Indazol-6-yl]thio]Benzamide; Benzamide,N-Methyl-2-[[3-[(1E)-2-(2-Pyridinyl)Ethenyl]-1H-Indazol-6-yl]thio]-; AG-013736; Brandname:Inlyta; AG-013736 N-Methyl-2-((3-((1E)-2-(Pyridin-2-yl)Ethenyl)-1H-Indazol-6-yl)Sulfanyl)Benzamide; Axtinib; [14C]-Axitinib

Brief Introduction

Axitinib is a white powder with a melting point of 218.4°C, slightly soluble in polyethylene glycol 400, slightly soluble in methanol or ethanol, very slightly soluble in acetonitrile, and almost insoluble in water. The solubility is 0.8 mg/ml in pH1.2 hydrochloric acid solution at 20°C, and 0.2 micrograms/ml in phosphate buffer solution at pH 6.8, which is a typical pH-dependent drug.

1
···
19
20
21
22
23
24
25
26
27

Inquiry (

/ 10

)

Clear All